ZLAB · Zai Lab Ltd
$21.53
+3.16 (+17.17%)
At close · Aug 6
Earnings today
View the 10-Q filed May 7, 2026
Customer concentration
— top customer 25% of receivables
One customer — 25% of receivables (As of March 31, 2026)
“As of March 31, 2026, our largest customer accounted for approximately 25% of our total accounts receivable collectively.”
Market Cap
$26.89B
Shares
1.46B
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ZLAB
42 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Baron Emerging Markets Fund | — | 1,383,035 | $26,014,888 | 0.76% | Long | 2026-03-31 | |
| Fidelity Series Emerging Markets Fund | — | 894,582 | $19,358,754 | 0.25% | Long | 2026-04-30 | |
| Strategic Advisers Fidelity Emerging Markets Fund | — | 738,509 | $13,064,224 | 0.03% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | — | 613,747 | $11,544,581 | 0.14% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 332,190 | $5,876,441 | 0.01% | Long | 2026-05-31 | |
| abrdn World Healthcare Fund | THW | 237,739 | $4,471,871 | 0.93% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 213,174 | $4,009,803 | 0.04% | Long | 2026-03-31 | |
| Strategic Advisers Emerging Markets Fund | — | 204,400 | $3,615,836 | 0.02% | Long | 2026-05-31 | |
| Fidelity Pacific Basin Fund | — | 162,700 | $3,520,828 | 0.30% | Long | 2026-04-30 | |
| Tema Oncology ETF | — | 196,972 | $3,484,435 | 1.98% | Long | 2026-05-31 | |
| Fidelity Growth Company K6 Fund | — | 131,934 | $2,333,912 | 0.01% | Long | 2026-05-31 | |
| ALPS Medical Breakthroughs ETF | — | 115,031 | $2,034,898 | 1.26% | Long | 2026-05-31 | |
| Baron International Growth Fund | — | 81,821 | $1,539,053 | 0.53% | Long | 2026-03-31 | |
| Fidelity Series Growth Company Fund | — | 77,700 | $1,374,513 | 0.01% | Long | 2026-05-31 | |
| Destinations International Equity Fund | — | 75,566 | $1,336,763 | 0.06% | Long | 2026-05-31 | |
| Virtus Biotech Etf | — | 53,256 | $1,152,460 | 1.94% | Long | 2026-04-30 | |
| THE EMERGING MARKETS SMALL CAP SERIES | — | 46,914 | $1,015,219 | 0.03% | Long | 2026-04-30 | |
| Dimensional Emerging Markets Core Equity 2 ETF | — | 28,261 | $611,568 | 0.01% | Long | 2026-04-30 | |
| Invesco Golden Dragon China ETF | — | 24,621 | $532,798 | 0.46% | Long | 2026-04-30 | |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO | — | 22,834 | $494,128 | 0.00% | Long | 2026-04-30 | |
| Fidelity SAI Sustainable Emerging Markets Equity Fund | — | 22,330 | $483,221 | 0.40% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 23,879 | $422,420 | 0.00% | Long | 2026-05-31 | |
| Dimensional Emerging Core Equity Market ETF | — | 17,797 | $385,127 | 0.00% | Long | 2026-04-30 | |
| Fidelity Disruptive Medicine ETF | — | 15,273 | $270,179 | 0.66% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 13,777 | $259,145 | 0.04% | Long | 2026-03-31 | |
| Emerging Markets Sustainability Core 1 Portfolio | — | 8,251 | $178,552 | 0.01% | Long | 2026-04-30 | |
| Health Sciences Trust | — | 8,626 | $162,255 | 0.07% | Long | 2026-03-31 | |
| Fidelity Sustainable Emerging Markets Equity Fund | — | 6,052 | $130,965 | 0.40% | Long | 2026-04-30 | |
| ULTRACHINA PROFUND | — | 5,389 | $116,618 | 0.52% | Long | 2026-04-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 5,474 | $102,966 | 0.06% | Long | 2026-03-31 | |
| National Security Emerging Markets Index ETF | — | 4,627 | $81,852 | 0.20% | Long | 2026-05-31 | |
| Dimensional World ex. U.S. Core Equity 2 ETF | — | 2,911 | $62,994 | 0.00% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF | — | 2,340 | $44,015 | 0.00% | Long | 2026-03-31 | |
| Dimensional Emerging Markets Sustainability Core 1 ETF | — | 1,660 | $35,922 | 0.01% | Long | 2026-04-30 | |
| Invesco Nasdaq Biotechnology ETF | — | 1,809 | $32,001 | 0.05% | Long | 2026-05-31 | |
| Emerging Markets Social Core Equity Portfolio | — | 1,400 | $30,296 | 0.00% | Long | 2026-04-30 | |
| ProShares Ultra Nasdaq Biotechnology | — | 1,269 | $22,449 | 0.03% | Long | 2026-05-31 | |
| World ex U.S. Core Equity Portfolio | — | 985 | $21,315 | 0.00% | Long | 2026-04-30 | |
| WisdomTree Emerging Markets Efficient Core Fund | — | 425 | $7,994 | 0.02% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 400 | $7,524 | 0.00% | Long | 2026-03-31 | |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | — | 147 | $2,600 | 0.00% | Long | 2026-05-29 | |
| Even Herd Long Short ETF | — | 8,202 | $154,280 | -0.27% | Short | 2026-03-31 |
Showing 1–42 of 42 positions
Key facts
CIK
1704292
CUSIP
98887Q104
13F (30d)
31 filings
19 filers
Visit website
Investor relations